Stocktoria

NEOGEN CORP NEOG

Nasdaq · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 1989-08-23 · LEI

NEOGEN CORP statistics & valuation

P / S2.4×
P / B1.0×
Net margin-0.9%
Net debt$608.2M
Net debt / EBITDA6.4×
Enterprise value USD$2.7B
EV / EBITDA28.4×
Earnings yield EBIT/EV-0.8%
Return on capital-0.7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
12.10% 15.90% 14.50% 14.20% 13.00% 9.20% -2.80% -1.00% -122.10% -0.90% 2017201820192020202120222023202420252026
Gross margin (%)
46.70% 46.80% 46.30% 46.90% 45.90% 46.10% 49.40% 50.20% 47.10% 46.90% 2017201820192020202120222023202420252026
Operating margin (%)
18.00% 17.60% 16.40% 16.10% 15.80% 11.10% 4.60% 6.30% -118.60% -2.50% 2017201820192020202120222023202420252026
Return on equity (%)
9.30% 11.30% 9.40% 8.20% 7.20% 5.40% -0.70% -0.30% -52.70% -0.40% 2017201820192020202120222023202420252026
Shares outstanding
204.7M 208.6M 209.7M 211.8M 214.9M 216.0M 216.2M 217.0M 217.0M 217.7M 2017201820192020202120222023202420252026
Net debt ($)
-$44.5M $722.2M $717.8M $745.8M $608.2M 2017201820192020202120222023202420252026
Share buybacks ($)
2017201820192020202120222023202420252026
Return on assets (%)
8.30% 10.20% 8.60% 7.50% 6.60% 4.90% -0.50% -0.20% -31.70% -0.20% 2017201820192020202120222023202420252026
Free cash flow margin (%)
2017201820192020202120222023202420252026
Debt / equity (×)
0.00× 0.28× 0.28× 0.42× 0.38× 2017201820192020202120222023202420252026
EPS ($)
$0.21 $0.30 $0.28 $0.28 $0.28 $0.23 -$0.12 -$0.04 -$5.03 -$0.04 2017201820192020202120222023202420252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

NEOGEN CORP trades at about 50.9× earnings — below its 10-year norm (10-year range 74.1×–161.5×, median 117.2×).

50.9× 161.5×

Shaded band = 10-year range (74.1×–161.5×); dot = today's 50.9×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Gross margin46.9%47.1%50.2%49.4%46.1%45.9%46.9%46.3%46.8%46.7%
Operating margin-2.5%-118.6%6.3%4.6%11.1%15.8%16.1%16.4%17.6%18.0%
Net margin-0.9%-122.1%-1.0%-2.8%9.2%13.0%14.2%14.5%15.9%12.1%
Return on assets-0.2%-31.7%-0.2%-0.5%4.9%6.6%7.5%8.6%10.2%8.3%
Return on equity-0.4%-52.7%-0.3%-0.7%5.4%7.2%8.2%9.4%11.3%9.3%
Debt / equity0.38×0.42×0.28×0.28×0.00×
Current ratio3.823.323.824.038.0511.0311.0811.759.718.14

Computed from company filings · US · as of 2025-05-31. Facts plus Stocktoria's own computed scores — not investment advice.